| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| TAX PREPARATION FEES | 4,450 | 0 | 0 | 4,450 |
| Identifier | Return Reference | Explanation |
|---|---|---|
| PART I, LINE 23 & PART II, LINE 15 | PATENT AMORTIZATION EXPENSE | DATE ACQUIRED 1/1/2014PATENT ORIGINAL VALUE $1,000,000 2023 AMORTIZATION $(84,531) DEDUCTION IN PRIOR YEARS $(676,248) ------------TOTAL AMORTIZATION $(760,779) ------------PATENT NET VALUE $239,221 ------------ ------------ |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| COOLEY LLP | 136,474 | 0 | 0 | 127,870 |
| FOX ROTHSCHILD LLP | 31,331 | 0 | 0 | 77,877 |
| LOEB, BLOCK & PARTNERS LLP | 760 | 0 | 0 | 760 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| INTANGIBLE ASSET (R&D) | 323,752 | 239,221 | 239,221 |
| DUE FROM THIRD PARTIES | 20 | 29,406 | 29,406 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PHARMACEUTICAL RESEARCH PROFESSIONAL SERVICES | 1,899,962 | 0 | 0 | 1,392,995 |
| DIRECT PROGRAM | 589,708 | 0 | 0 | 588,621 |
| ADMINISTRATIVE | 112,312 | 4,965 | 0 | 107,348 |
| PATENT AMORTIZATION | 84,531 | 0 | 0 | 0 |
| INFORMATION TECHNOLOGY | 22,561 | 0 | 0 | 22,234 |
| CLINICAL TRIAL INSURANCE | 20,389 | 0 | 0 | 20,389 |
| EMPLOYEE DEVELOPMENT | 3,366 | 0 | 0 | 3,346 |
| PUBLIC RELATIONS & COMMUNICATIONS | 1,408 | 0 | 0 | 1,408 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| DUE TO THE SIMONS FOUNDATION | 295,974 | 65,659 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| HUMAN RESOURCES CONSULTING | 1,769 | 0 | 0 | 1,929 |